Xpert MTB/XDR implementation in South Africa: cost outcomes of centralised vs. decentralised approaches

Xpert MTB/XDR implementation in South Africa: cost outcomes of centralised vs. decentralised approaches

INTRODUCTION: In South Africa, Xpert® MTB/RIF Ultra (Ultra) is the recommended diagnostic assay for TB with line-probe assays for first- (LPAfl) and second-line drugs (LPAsl) providing additional drug susceptibility testing (DST) for samples that were rifampicin-resistant (RR-TB). To guide implement...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. Cassim, S.V. Omar, S.D. Masuku, H. Moultrie, W.S. Stevens, F. Ismail, P. da Silva
Format:	Article
Language:	English
Published:	International Union Against Tuberculosis and Lung Disease (The Union) 2024-05-01
Series:	IJTLD Open
Subjects:	drug susceptibility testing rifampicin-resistant tuberculosis multidrug-resistant tuberculosis line-probe assay
Online Access:	https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000005/art00004
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of extracts from used Xpert MTB/RIF cartridges for detection of resistance to second-line anti-tuberculosis drugs in patients with multidrug-resistant tuberculosis in Ethiopia
by: Tilahun Ketema, et al.
Published: (2025-01-01)

Association between the rifampicin resistance mutations and rifabutin susceptibility in Mycobacterium tuberculosis: A meta-analysis
by: Wenli Wang, et al.
Published: (2025-01-01)

A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB
by: A. Vasquez, et al.
Published: (2024-07-01)

Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region
by: G.B. Migliori, et al.
Published: (2024-03-01)

Whole genomic analysis uncovers high genetic diversity of rifampicin-resistant Mycobacterium tuberculosis strains in Botswana
by: Tuelo Mogashoa, et al.
Published: (2025-02-01)

Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus
by: Lianpeng Wu, et al.
Published: (2025-01-01)

Sequential testing with Xpert MTB/RIF assay for diagnosis of tuberculous meningitis in Maharaj Nakorn Chiang Mai University Hospital
by: Poramed Winichakoon, et al.
Published: (2025-01-01)

TB and poverty: the effect of rifampicin-resistant TB on household income
by: A. Ciobanu, et al.
Published: (2024-04-01)

Peptide nucleic acid-immobilised paper combined with multiplex recombinase polymerase amplification for the ultrasensitive and rapid detection of rifampicin-resistant tuberculosis
by: Nuttapon Jirakittiwut, et al.
Published: (2025-01-01)

Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review
by: Denise Rossato Silva, et al.
Published: (2025-01-01)

Tuberculosis vaccines and therapeutic drug: challenges and future directions
by: Yajing An, et al.
Published: (2025-01-01)

Effect of rifampicin on the kidney of albino rats
by: DE Peters, et al.
Published: (2013-07-01)

Analytical and clinical validation of a novel MeltPlus TB-NTM/RIF platform for simultaneous detection of Mycobacterium tuberculosis complex, Non-Tuberculous Mycobacteria and rifampicin resistance
by: Zhuo Wang, et al.
Published: (2025-02-01)

Role of Chest Radiography in Diagnosing Pulmonary Tuberculosis, Does Every Suspected Case Needs GeneXpert MTB; A Cross-Sectional Study
by: Mujahid Raza, et al.
Published: (2025-02-01)

Multidrug Resistance Tuberculosis in the Context of Co-Infection in Ethiopia: A Systematic Review and Meta-Analysis
by: Bezawit Kassaw Hailu, et al.
Published: (2025-02-01)

Real-life use of delamanid: results from the European post-authorisation safety study
by: N. Schönfeld, et al.
Published: (2024-06-01)

Assessment of Rifampicin Resistance in Presumptive Tuberculosis Cases at Dadeldhura Hospital of Sudurpaschim Province of Nepal
by: Madan Singh Bohara
Published: (2025-02-01)

Regional insights on the prevalence and antimicrobial susceptibility pattern of carbapenem and colistin-resistant gram-negative bacteria: an observational cross-sectional study from Karachi, Pakistan
by: Nazia Khursheed, et al.
Published: (2025-02-01)

Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China
by: Liqing Wei, et al.
Published: (2025-01-01)

Stool Xpert® MTB/RIF Ultra for TB diagnosis in children: experience from a national scale-up programme
by: S. Kabir, et al.
Published: (2024-10-01)

Drug-induced differential culturability in diverse strains of Mycobacterium tuberculosis
by: Valerie F. A. March, et al.
Published: (2025-01-01)

2022 TB programme review in Pakistan: strengthening governance, with better patient diagnosis and treatment
by: M. van den Boom, et al.
Published: (2024-03-01)

Comprehensive genomic surveillance reveals transmission profiles of extensively drug-resistant tuberculosis cases in Pará, Brazil
by: Davi Josué Marcon, et al.
Published: (2025-01-01)

Drug-resistant tuberculosis is an important challenge in long COVID patients
by: Masoud Mohammadi, et al.
Published: (2025-03-01)

Rifampicin liposomes loaded on calcium phosphate cement scaffold constructed using 3D printing technology for sustained drug release
by: Jie Jin, et al.
Published: (2025-01-01)

Protease shaving of Mycobacterium tuberculosis facilitates vaccine antigen discovery and delivery of novel cargoes to the Mtb surface
by: Bianca A. Lepe, et al.
Published: (2025-02-01)

Mapping Drug-Resistant Tuberculosis Treatment Outcomes in Hunan Province, China
by: Temesgen Yihunie Akalu, et al.
Published: (2024-12-01)

Diagnostic value of interferon-γ release assay in patients with COPD complicated with pulmonary tuberculosis
by: Yanxiao Rong, et al.
Published: (2025-01-01)

A two-strain TB model with multiplelatent stages
by: Azizeh Jabbari, et al.
Published: (2016-04-01)

Extrapulmonary, bone and intestinal tuberculosis. Case report
by: Dianelí Lorely Reyes Hernández, et al.
Published: (2024-05-01)

Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia
by: Mokhtar JA, et al.
Published: (2025-02-01)

Impact of heteroresistance on treatment outcomes of people with drug-resistant TB
by: R. Crowder, et al.
Published: (2024-10-01)

Assessment of Haematological Parameters in Drug-Resistant TB
by: Abdulrazzaq Neamah Zghair
Published: (2023-03-01)

Understanding Rifampicin Resistance in Tuberculosis through a Computational Approach
by: Satish Kumar, et al.
Published: (2014-12-01)

Serine/threonine protein kinase mediates rifampicin resistance in Brucella melitensis through interacting with ribosomal protein RpsD and affecting antioxidant capacity
by: Yaqin Yuan, et al.
Published: (2025-01-01)

Cartridge-based sequencing for bedaquiline resistance detection from sputum
by: J.D. Limberis, et al.
Published: (2024-09-01)

Geospatial mapping of drug-resistant tuberculosis prevalence in Africa at national and sub-national levels
by: Alemneh Mekuriaw Liyew, et al.
Published: (2025-04-01)

The impact of the COVID-19 pandemic on TB notifications in Ukraine in 2020
by: A.N. Shapiro, et al.
Published: (2024-06-01)

The impact of maximum cross-sectional area of lesion on predicting the early therapeutic response of multidrug-resistant tuberculosis
by: Fuzhen Zhang, et al.
Published: (2025-02-01)

Genome‐wide association study of tuberculosis in the western Chinese Han and Tibetan population
by: Hao Bai, et al.
Published: (2023-04-01)